Literature DB >> 9059132

Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing.

A T Masi1, G P Chrousos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9059132      PMCID： PMC1752247          DOI： 10.1136/ard.56.1.1

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  33 in total

1.  Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function.

Authors:  A W Meikle; F H Tyler
Journal:  Am J Med       Date:  1977-08       Impact factor: 4.965

2.  The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.

Authors:  J R Kirwan
Journal:  N Engl J Med       Date:  1995-07-20       Impact factor: 91.245

Review 3.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

Authors:  G P Chrousos
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

4.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

Authors:  C Slemenda; C Longcope; M Peacock; S Hui; C C Johnston
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 5.  Perturbations of hypothalamic-pituitary-gonadal (HPG) axis and adrenal androgen (AA) functions in rheumatoid arthritis.

Authors:  A T Masi; J A Da Silva; M Cutolo
Journal:  Baillieres Clin Rheumatol       Date:  1996-05

6.  Circadian characteristics of circulating interleukin-6 in men.

Authors:  R B Sothern; B Roitman-Johnson; E L Kanabrocki; J G Yager; M M Roodell; J A Weatherbee; M R Young; B M Nenchausky; L E Scheving
Journal:  J Allergy Clin Immunol       Date:  1995-05       Impact factor: 10.793

7.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

8.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.

Authors:  T Bellido; R L Jilka; B F Boyce; G Girasole; H Broxmeyer; S A Dalrymple; R Murray; S C Manolagas
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 9.  Integrated hormonal-immunological-vascular (H-I-V triad) systems interactions in the rheumatic diseases.

Authors:  A T Masi; S L Feigenbaum; R T Chatterton; M Cutolo
Journal:  Clin Exp Rheumatol       Date:  1995 Mar-Apr       Impact factor: 4.473

10.  Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor.

Authors:  M Mihara; Y Moriya; T Kishimoto; Y Ohsugi
Journal:  Br J Rheumatol       Date:  1995-04
View more
  3 in total

Review 1.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

2.  Effect of histamine on the production of matrix metalloproteinases-1, -3, -8 and -13, and TNFalpha and PGE(2) by human articular chondrocytes and synovial fibroblasts in vitro: a comparative study.

Authors:  Lynne C Tetlow; David E Woolley
Journal:  Virchows Arch       Date:  2004-09-17       Impact factor: 4.064

Review 3.  Circadian rhythms in rheumatology--a glucocorticoid perspective.

Authors:  Cornelia M Spies; Rainer H Straub; Maurizio Cutolo; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2014-11-13       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.